HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.053454v1 49/11/1763    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Langen, A. J. Articles by Lammertsma, A. A. Search for Related Content PubMed PubMed Citation Articles by de Langen, A. J. Articles by Lammertsma, A. A.

Reproducibility of Tumor Perfusion Measurements Using ¹⁵O-Labeled Water and PET

¹ Department of Respiratory Medicine, VU University Medical Centre, Amsterdam, The Netherlands; ² Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands; and ³ Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands

Correspondence: For correspondence or reprints contact: Adriaan A. Lammertsma, Department of Nuclear Medicine and PET Research, VU University Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: aa.lammertsma{at}vumc.nl

PET and ¹⁵O-labeled water (H₂¹⁵O) can be used to noninvasively monitor tumor perfusion. This allows evaluation of the direct target of antiangiogenic drugs, that is, tumor vasculature. Because these drugs often result in consolidation rather than regression of the tumor mass, a change in perfusion might be a more sensitive way to evaluate response than are indirect size measures on a CT scan. However, to use the technique for serial imaging of individual patients, good reproducibility is essential. The purpose of the present study was to evaluate the reproducibility of quantitative H₂¹⁵O measurements. Methods: Nine patients with non–small-cell lung cancer (NSCLC) were scanned twice within 7 d and before any therapy. All H₂¹⁵O scans were followed by an ¹⁸F-fluorothymidine scan to allow for adequate volume-of-interest (VOI) definition. VOIs were defined using a 3-dimensional threshold technique. Tumor perfusion and the volume of distribution (V_T) were obtained using a 1-tissue-compartment model including an arterial blood volume component and an image-derived input function. The level of agreement between test and retest values was assessed using the intraclass correlation coefficient (ICC) and Bland–Altman analyses. Possible dependency on absolute values and lesion size was assessed by linear regression. Results: All primary tumors and more than 90% of clinically suspected locoregional metastases could be delineated. In total, 14 lesions in 9 patients were analyzed. Tumor perfusion showed excellent reproducibility, with an ICC of 0.95 and SD of 9%. The V_T was only moderately reproducible, with an ICC of 0.52 and SD of 16%. No dependency was found on absolute values of perfusion (P = 0.14) and V_T (P = 0.15). In addition, tumor volume did not influence the reproducibility of perfusion (P = 0.46) and V_T (P = 0.25). Conclusion: Quantitative measurements of tumor perfusion using H₂¹⁵O and PET are reproducible in NSCLC. When patients are repeatedly being scanned during therapy, changes of more than 18% in tumor perfusion and 32% in V_T (>1.96 x SD) are likely to represent treatment effects.

Key Words: positron emission tomography • blood flow • perfusion • non–small-cell lung cancer

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  

This article has been cited by other articles:

				G. Komar, S. Kauhanen, K. Liukko, M. Seppanen, S. Kajander, J. Ovaska, P. Nuutila, and H. Minn Decreased Blood Flow with Increased Metabolic Activity: A Novel Sign of Pancreatic Tumor Aggressiveness Clin. Cancer Res., September 1, 2009; 15(17): 5511 - 5517. [Abstract] [Full Text] [PDF]